---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-200205"
form_type: "8-K"
ticker: "RAPP"
cik: "0002012593"
company_name: "Rapport Therapeutics, Inc."
filed_at: "2025-09-10T23:59:59+00:00"
generated_at: "2026-05-17T07:08:00.812854+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Rapport Therapeutics announces $234.7M public offering of 9.6M shares at $26.00 per share

## Summary
- Underwriting agreement for 9,615,385 shares at $26.00; underwriters option for up to 1,442,307 additional shares.
- Net proceeds estimated at $234.7 million (excluding over-allotment).
- Proceeds to fund RAP-219 clinical trials, R&D, and working capital.
- Closing expected on or about September 11, 2025.

## SEC filing metadata
- accession: 0001193125-25-200205
- form_type: 8-K
- ticker: RAPP
- cik: 0002012593
- company_name: Rapport Therapeutics, Inc.
- filed_at: 2025-09-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/0001193125-25-200205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/d907117d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-200205
- JSON: https://secwatch.observer/filing/0001193125-25-200205.json
- Plain text: https://secwatch.observer/filing/0001193125-25-200205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.